Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Torizuka T, Tamaki N, Inokuma T et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995;36(10):1811–1817.
Minn H, Clavo AC, Wahl RL. Influence of hypoxia on tracer accumulation in squamous cell carcinoma: in vitro evaluation for PET imaging. Nucl Med Biol 1996;23:941–946.
Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumour and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992;183:643–647.
Torizuka T, Clavo AC, Wahl RL. Effect of hyperglycaemia on in vitro tumour uptake of tritiated FDG, thymidine, L-methionine and L-leucine. J Nucl Med 1997;38:382–386.
Yasuda S, Kajihara M, Fujii H, Takahashi W, Ide M, Shohtsu A. Factors influencing high FDG uptake in the intestine, skeletal muscle and myocardium. J Nucl Med 1999;40:140P.
Torizuka T, Fisher SJ, Wahl RL. Insulin induced hypoglycaemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma. Radiology 1997;203:169–172.
Yamada S, Kubota K, Kubota R et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36:1301–1306.
Kubota R, Kubota K, Yamada S et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484–492.
Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998;25:1238–1243.
Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280–287.
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409–1415.
Haberkorn U, Strauss LG, Dimitrakopoulou A et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485–1490.
Kubota R, Kubota K, Yamada S et al. Methionine uptake by tumour tissue: a microautoradiographic comparison with 18FDG. J Nucl Med 1995;36:484–492.
Nuutinen JM, Leskinen S, Elomaa I et al. Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer. 1997;33:1234–1241.
Jones DN, McCowage GB, Sostman HD et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996;37:1438–1444.
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
Kato T, Tsukamoto E, Suginami Y et al. Visualization of normal organs in whole-body FDG-PET imaging. Jpn J Nucl Med 1999;36:971–977.
Yasuda S, Shohtsu A, Ide M et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998;207:775–778.
Miyauchi T. Wahl RL. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med 1996; 23:517–523.
Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R. Reevaluation of myocardial FDG uptake in hyperglycaemia. J Nucl Med 1996;37:1713–1717.
Knuuti MJ, Maki M, Yki-Jarvinen et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 1995;27:1359–1367.
Choi Y, Brunken RC, Hawkins RA et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20:308–318.
Bax JJ, Visser FC, Raymakers PG et al. Cardiac 18F-FDG-SPET studies in patients with non-insulin dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping. Nucl Med Commun 1997;18:200–206.
Huitink JM, Visser FC, van Leeuwen GR et al. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle assessed by planar imaging. Eur J Nucl Med 1995;22:1141–1148.
Locher JT, Frey LD, Seybold K, Jenzer H. Myocardial 18F-FDG-PET. Experiences with the euglycaemic hyperinsulinaemic clamp technique. Angiology 1995;46:313–320.
Ohtake T, Yokoyama I, Watanabe T et al. Myocardial glucose metabolism in noninsulin dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995;36:456–463.
Bax JJ, Veening MA, Visser FC et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: a comparative study using different protocols. Eur J Nucl Med 1997;24:35–41.
Engel H, Steinert H, Buck A et al. Whole body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–446.
Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308–314.
Cook GJR, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999;26:1363–1378.
Hany TF, Gharehpapagh E, Kamel EM et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med 2002;29:1393–1398.
Bischof Delalove A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995;36:106P.
Nakada K, Fisher SJ, Brown RS, Wahl RL. FDG uptake in the gastrointestinal tract: can it be reduced? J Nucl Med 1999;40:22P–23P.
Kosuda S, Fisher S, Kison PV, Wahl RL, Grossman HB. Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med 1997;11:195–199.
Picard Y, Thompson CJ. Motion correction of PET images using multiple acquisition frames. IEEE Trans Med Imaging 1997;16:137–144.
Nunez RF, Yeung HW, Macapinlac HA, Larson SM. Does post-radiation therapy changes in the lung affect the accuracy of FDG PET in the evaluation of tumour recurrence in lung cancer. J Nucl Med 1999;40:234P.
Diederichs CG, Staib L, Vogel J et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 2000;20:109–116.
Knopp MV, Bischoff HG. Evaluation of pulmonary lesions with positron emission tomography. Radiologe 1994;34:588–591.
Lewis PJ, Salama A. Uptake of Fluorine-18-Fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1–3.
O’Doherty MJ, Barrington SF, Campbell M, et al; PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575–1583.
Goerres GW, Kamel E, Seifert B et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002;43:1469–1475.
Goerres GW, Kamel E, Heidelberg TN et al. PET-CT image coregistration in the thorax: influence of respiration. Eur J Nucl Med 2002;29:351–360.
Goerres GW, Burger C, Schwitter MR et al. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 2003;13:734–739.
Osman MM, Cohade C, Nakamoto Y et al. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 2003;44:240–243.
Dizendorf E, Hany TF, Buck A et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 2003;44:732–738.
Goerres GW, Hany TF, Kamel E et al. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med 2002;29:367–370.
Kamel EM. Burger C. Buck A. von Schulthess GK. Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 2003;13:724–728.
Antoch G, Freudenberg LS, Egelhof T et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339–1342.
Cohade C, Wahl RL. Applications of PET/CT image fusion in clinical PET — Clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33:228–237.
Goerres GW, Ziegler SI, Burger C et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003;226:577–584.
Kinahan PE, Hasegawa BH, Beyer T. X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med 2003;33:166–179.
Cohade C, Osman M, Nakamoto Y et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003;44:412–416.
Dizendorf EV, Treyer V, Von Schulthess Gk et al. Application of oral contrast media in coregistered positron emission tomography-CT. AJR 2002;179:477–481.
Hany TF, Steinert HC, Goerres GW et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225:575–581.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Cook, G.J.R. (2005). Artefacts and Normal Variants in Whole-Body PET and PET/CT Imaging. In: Bailey, D.L., Townsend, D.W., Valk, P.E., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London. https://doi.org/10.1007/1-84628-007-9_14
Download citation
DOI: https://doi.org/10.1007/1-84628-007-9_14
Publisher Name: Springer, London
Print ISBN: 978-1-85233-798-8
Online ISBN: 978-1-84628-007-8
eBook Packages: MedicineMedicine (R0)